Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa

Clinical trial NCT01693029 · COMPLETED

Trial details

NCT number: NCT01693029
Sponsor: Sandoz
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anemia Chronic Kidney Disease (CKD)

Start date: 2012-09-01
Primary completion: 2014-05-01
Enrollment: 435

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.